Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 487

1.

Aracaniform Swimming: A Proposed New Category of Swimming Mode in Bony Fishes (Teleostei: Tetraodontiformes: Aracanidae).

Gordon MS, Lauritzen DV, Wiktorowicz-Conroy AM, Rutledge KM.

Physiol Biochem Zool. 2020 May/Jun;93(3):235-242. doi: 10.1086/708163.

PMID:
32255729
2.

BRAF-mutant Transcriptional Subtypes Predict Outcome of Combined BRAF, MEK, and EGFR Blockade with Dabrafenib, Trametinib, and Panitumumab in Patients with Colorectal Cancer.

Middleton G, Yang Y, Campbell CD, André T, Atreya CE, Schellens JHM, Yoshino T, Bendell JC, Hollebecque A, McRee AJ, Siena S, Gordon MS, Tabernero J, Yaeger R, O'Dwyer PJ, De Vos F, Van Cutsem E, Millholland JM, Brase JC, Rangwala F, Gasal E, Corcoran RB.

Clin Cancer Res. 2020 Feb 11. pii: clincanres.3579.2019. doi: 10.1158/1078-0432.CCR-19-3579. [Epub ahead of print]

3.

A Phase 1 Study of ASTX660, an Antagonist of Inhibitors of Apoptosis Proteins, in Adults With Advanced Cancers or Lymphoma.

Mita MM, LoRusso PM, Papadopoulos KP, Gordon MS, Mita AC, Ferraldeschi R, Keer H, Oganesian A, Su XY, Jueliger S, Tolcher AW.

Clin Cancer Res. 2020 Jan 3. pii: clincanres.1430.2019. doi: 10.1158/1078-0432.CCR-19-1430. [Epub ahead of print]

4.

Development of the FMO/RI-MP2 Fully Analytic Gradient Using a Hybrid-Distributed/Shared Memory Programming Model.

Pham BQ, Gordon MS.

J Chem Theory Comput. 2020 Feb 11;16(2):1039-1054. doi: 10.1021/acs.jctc.9b01082. Epub 2020 Jan 27.

PMID:
31899632
5.

Analytic non-adiabatic couplings for the spin-flip ORMAS method.

Mato J, Gordon MS.

Phys Chem Chem Phys. 2020 Jan 21;22(3):1475-1484. doi: 10.1039/c9cp05849d. Epub 2019 Dec 23.

PMID:
31868182
6.

Longitudinal analysis of HIV-risk behaviors of participants in a randomized trial of prison-initiated buprenorphine.

Blue TR, Gordon MS, Schwartz RP, Couvillion K, Vocci FJ, Fitzgerald TT, O'Grady KE.

Addict Sci Clin Pract. 2019 Dec 2;14(1):45. doi: 10.1186/s13722-019-0172-2.

7.

A Phase I Study of LY3009120, a Pan-RAF Inhibitor, in Patients with Advanced or Metastatic Cancer.

Sullivan RJ, Hollebecque A, Flaherty KT, Shapiro GI, Rodon Ahnert J, Millward MJ, Zhang W, Gao L, Sykes A, Willard MD, Yu D, Schade AE, Crowe K, Flynn DL, Kaufman MD, Henry JR, Peng SB, Benhadji KA, Conti I, Gordon MS, Tiu RV, Hong DS.

Mol Cancer Ther. 2020 Feb;19(2):460-467. doi: 10.1158/1535-7163.MCT-19-0681. Epub 2019 Oct 23.

PMID:
31645440
8.

Individual differences in the acoustic properties of human skulls.

Gordon MS, Hall MD, Gaston J, Foots A, Suwangbutra J.

J Acoust Soc Am. 2019 Sep;146(3):EL191. doi: 10.1121/1.5124321.

PMID:
31590503
9.

Patient-reported outcomes and inflammatory biomarkers in patients with locally advanced/metastatic urothelial carcinoma treated with durvalumab in phase 1/2 dose-escalation study 1108.

O'Donnell PH, Arkenau HT, Sridhar SS, Ong M, Drakaki A, Spira AI, Zhang J, Gordon MS, Degboe AN, Gupta AK, Mukhopadhyay P, Huang W, Abdullah SE, Angra N, Roskos LK, Guo X, Friedlander T.

Cancer. 2020 Jan 15;126(2):432-443. doi: 10.1002/cncr.32532. Epub 2019 Oct 3.

PMID:
31581306
10.

Response Rate Following Albumin-Bound Paclitaxel Plus Gemcitabine Plus Cisplatin Treatment Among Patients With Advanced Pancreatic Cancer: A Phase 1b/2 Pilot Clinical Trial.

Jameson GS, Borazanci E, Babiker HM, Poplin E, Niewiarowska AA, Gordon MS, Barrett MT, Rosenthal A, Stoll-D'Astice A, Crowley J, Shemanski L, Korn RL, Ansaldo K, Lebron L, Ramanathan RK, Von Hoff DD.

JAMA Oncol. 2019 Oct 3. doi: 10.1001/jamaoncol.2019.3394. [Epub ahead of print] Erratum in: JAMA Oncol. 2019 Nov 1;5(11):1643.

PMID:
31580386
11.

Phase Ia Study of Anti-NaPi2b Antibody-Drug Conjugate Lifastuzumab Vedotin DNIB0600A in Patients with Non-Small Cell Lung Cancer and Platinum-Resistant Ovarian Cancer.

Gerber DE, Infante JR, Gordon MS, Goldberg SB, Martín M, Felip E, Martinez Garcia M, Schiller JH, Spigel DR, Cordova J, Westcott V, Wang Y, Shames DS, Choi Y, Kahn R, Dere RC, Samineni D, Xu J, Lin K, Wood K, Royer-Joo S, Lemahieu V, Schuth E, Vaze A, Maslyar D, Humke EW, Burris HA 3rd.

Clin Cancer Res. 2020 Jan 15;26(2):364-372. doi: 10.1158/1078-0432.CCR-18-3965. Epub 2019 Sep 20.

PMID:
31540980
12.

Hybrid Distributed/Shared Memory Model for the RI-MP2 Method in the Fragment Molecular Orbital Framework.

Pham BQ, Gordon MS.

J Chem Theory Comput. 2019 Oct 8;15(10):5252-5258. doi: 10.1021/acs.jctc.9b00409. Epub 2019 Sep 25.

PMID:
31509402
13.

Many-Body Dispersion in Molecular Clusters.

Alkan M, Xu P, Gordon MS.

J Phys Chem A. 2019 Oct 3;123(39):8406-8416. doi: 10.1021/acs.jpca.9b05977. Epub 2019 Sep 24.

PMID:
31497961
14.

The Influence of Parental Support and Community Belonging on Socioeconomic Status and Adolescent Substance Use over Time.

Gordon MS, Russell BS, Finan LJ.

Subst Use Misuse. 2020;55(1):23-36. doi: 10.1080/10826084.2019.1654513. Epub 2019 Aug 20.

PMID:
31429354
15.

An Accurate Quantum-Based Approach to Explicit Solvent Effects: Interfacing the General Effective Fragment Potential Method with Ab Initio Electronic Structure Theory.

Sattasathuchana T, Xu P, Gordon MS.

J Phys Chem A. 2019 Oct 3;123(39):8460-8475. doi: 10.1021/acs.jpca.9b05801. Epub 2019 Sep 24.

PMID:
31365250
16.

Ionic liquids from a fragmented perspective.

Conrad JA, Kim S, Gordon MS.

Phys Chem Chem Phys. 2019 Aug 21;21(31):16878-16888. doi: 10.1039/c9cp02836f. Epub 2019 Jul 30.

PMID:
31359024
17.

Expanding low-threshold buprenorphine to justice-involved individuals through mobile treatment: Addressing a critical care gap.

Krawczyk N, Buresh M, Gordon MS, Blue TR, Fingerhood MI, Agus D.

J Subst Abuse Treat. 2019 Aug;103:1-8. doi: 10.1016/j.jsat.2019.05.002. Epub 2019 May 9.

18.

Quasi-Atomic Bond Analyses in the Sixth Period: II. Bond Analyses of Cerium Oxides.

Schoendorff G, Schmidt MW, Ruedenberg K, Gordon MS.

J Phys Chem A. 2019 Jun 27;123(25):5249-5256. doi: 10.1021/acs.jpca.9b04024. Epub 2019 Jun 14.

PMID:
31199636
19.

Quasi-Atomic Bond Analyses in the Sixth Period: I. Relativistic Accurate Atomic Minimal Basis Sets for the Elements Cesium to Radon.

Schoendorff G, West AC, Schmidt MW, Ruedenberg K, Gordon MS.

J Phys Chem A. 2019 Jun 27;123(25):5242-5248. doi: 10.1021/acs.jpca.9b04023. Epub 2019 Jun 14.

PMID:
31199630
20.

Orbitals and the Interpretation of Photoelectron Spectroscopy and (e,2e) Ionization Experiments.

Truhlar DG, Hiberty PC, Shaik S, Gordon MS, Danovich D.

Angew Chem Int Ed Engl. 2019 Sep 2;58(36):12332-12338. doi: 10.1002/anie.201904609. Epub 2019 Jul 5. Review.

PMID:
31081208
21.

Spin-Orbit Coupling Constants in Atoms and Ions of Transition Elements: Comparison of Effective Core Potentials, Model Core Potentials, and All-Electron Methods.

Koseki S, Matsunaga N, Asada T, Schmidt MW, Gordon MS.

J Phys Chem A. 2019 Mar 28;123(12):2325-2339. doi: 10.1021/acs.jpca.8b09218. Epub 2019 Mar 12.

PMID:
30817150
22.

Compressing the Four-Index Two-Electron Repulsion Integral Matrix using the Resolution-of-the-Identity Approximation Combined with the Rank Factorization Approximation.

Pham BQ, Gordon MS.

J Chem Theory Comput. 2019 Apr 9;15(4):2254-2264. doi: 10.1021/acs.jctc.8b01256. Epub 2019 Mar 18.

PMID:
30811187
23.

A randomized controlled trial of buprenorphine for probationers and parolees: Bridging the gap into treatment.

Gordon MS, Vocci FJ, Taxman F, Fishman M, Sharma B, Blue TR, O'Grady KE.

Contemp Clin Trials. 2019 Apr;79:21-27. doi: 10.1016/j.cct.2019.02.009. Epub 2019 Feb 20.

24.

Analytic Gradients for the Spin-Flip ORMAS-CI Method: Optimizing Minima, Saddle Points, and Conical Intersections.

Mato J, Gordon MS.

J Phys Chem A. 2019 Feb 14;123(6):1260-1272. doi: 10.1021/acs.jpca.8b11569. Epub 2019 Jan 31.

PMID:
30645115
25.

Adverse events reported by anxious school refusing adolescents receiving cognitive behavioral therapy with and without fluoxetine.

Melvin GA, Finnin L, Taffe J, Dudley AL, Klimkeit EI, Gordon MS, Tonge B.

Clin Child Psychol Psychiatry. 2019 Oct;24(4):892-905. doi: 10.1177/1359104518822681. Epub 2019 Jan 12.

PMID:
30638065
26.

Pharmacotherapy for opioid addiction in community corrections.

Schwartz RP, Mitchell MM, O'Grady KE, Kelly SM, Gryczynski J, Mitchell SG, Gordon MS, Jaffe JH.

Int Rev Psychiatry. 2018 Oct;30(5):117-135. doi: 10.1080/09540261.2018.1524373. Epub 2018 Dec 6.

27.

Results of a Phase II Placebo-controlled Randomized Discontinuation Trial of Cabozantinib in Patients with Non-small-cell Lung Carcinoma.

Hellerstedt BA, Vogelzang NJ, Kluger HM, Yasenchak CA, Aftab DT, Ramies DA, Gordon MS, Lara P Jr.

Clin Lung Cancer. 2019 Mar;20(2):74-81.e1. doi: 10.1016/j.cllc.2018.10.006. Epub 2018 Oct 24.

28.

Incidence of future arrests in adults involved in the criminal justice system with opioid use disorder receiving extended release naltrexone compared to treatment as usual.

Soares WE 3rd, Wilson D, Gordon MS, Lee JD, Nunes EV, O'Brien CP, Shroff M, Friedmann PD.

Drug Alcohol Depend. 2019 Jan 1;194:482-486. doi: 10.1016/j.drugalcdep.2018.10.035. Epub 2018 Dec 3.

29.

A Quasi-Atomic Analysis of Three-Center Two-Electron Zr-H-Si Interactions.

Duchimaza Heredia JJ, Sadow AD, Gordon MS.

J Phys Chem A. 2018 Dec 20;122(50):9653-9669. doi: 10.1021/acs.jpca.8b09530. Epub 2018 Dec 11.

PMID:
30481021
30.

Approaches for creating comparable measures of alcohol use symptoms: Harmonization with eight studies of criminal justice populations.

Hussong AM, Gottfredson NC, Bauer DJ, Curran PJ, Haroon M, Chandler R, Kahana SY, Delaney JAC, Altice FL, Beckwith CG, Feaster DJ, Flynn PM, Gordon MS, Knight K, Kuo I, Ouellet LJ, Quan VM, Seal DW, Springer SA.

Drug Alcohol Depend. 2019 Jan 1;194:59-68. doi: 10.1016/j.drugalcdep.2018.10.003. Epub 2018 Oct 23.

31.

Application of a semi-empirical dispersion correction for modeling water clusters.

De Silva N, Adreance MA, Gordon MS.

J Comput Chem. 2019 Jan 15;40(2):310-315. doi: 10.1002/jcc.25596. Epub 2018 Oct 20.

PMID:
30368848
32.

E6201, an intravenous MEK1 inhibitor, achieves an exceptional response in BRAF V600E-mutated metastatic malignant melanoma with brain metastases.

Babiker HM, Byron SA, Hendricks WPD, Elmquist WF, Gampa G, Vondrak J, Aldrich J, Cuyugan L, Adkins J, De Luca V, Tibes R, Borad MJ, Marceau K, Myers TJ, Paradiso LJ, Liang WS, Korn RL, Cridebring D, Von Hoff DD, Carpten JD, Craig DW, Trent JM, Gordon MS.

Invest New Drugs. 2019 Aug;37(4):636-645. doi: 10.1007/s10637-018-0668-8. Epub 2018 Sep 28.

PMID:
30264293
33.

Long-term Clinical Outcomes and Biomarker Analyses of Atezolizumab Therapy for Patients With Metastatic Triple-Negative Breast Cancer: A Phase 1 Study.

Emens LA, Cruz C, Eder JP, Braiteh F, Chung C, Tolaney SM, Kuter I, Nanda R, Cassier PA, Delord JP, Gordon MS, ElGabry E, Chang CW, Sarkar I, Grossman W, O'Hear C, Fassò M, Molinero L, Schmid P.

JAMA Oncol. 2019 Jan 1;5(1):74-82. doi: 10.1001/jamaoncol.2018.4224.

34.

Solvation of the Glycyl Radical.

Chan B, Rintelman J, Wood GPF, Radom L, Gordon MS.

J Phys Chem A. 2018 Sep 13;122(36):7212-7217. doi: 10.1021/acs.jpca.8b06833. Epub 2018 Aug 30.

PMID:
30160481
35.

Proton Transfer in 1,2,4-Triazolium Dinitramide: Effect of Aqueous Microsolvation.

Conrad JA, Pruitt SR, Gordon MS.

J Phys Chem A. 2018 Sep 20;122(37):7443-7454. doi: 10.1021/acs.jpca.8b06348. Epub 2018 Sep 10.

PMID:
30129759
36.

Safety and clinical activity of atezolizumab monotherapy in metastatic non-small-cell lung cancer: final results from a phase I study.

Horn L, Gettinger SN, Gordon MS, Herbst RS, Gandhi L, Felip E, Sequist LV, Spigel DR, Antonia SJ, Balmanoukian A, Cassier PA, Liu B, Kowanetz M, O'Hear C, Fassò M, Grossman W, Sandler A, Soria JC.

Eur J Cancer. 2018 Sep;101:201-209. doi: 10.1016/j.ejca.2018.06.031. Epub 2018 Aug 1.

PMID:
30077125
37.

Perceived Invalidation in Adolescent Borderline Personality Disorder: An Investigation of Parallel Reports of Caregiver Responses to Negative Emotions.

Bennett C, Melvin GA, Quek J, Saeedi N, Gordon MS, Newman LK.

Child Psychiatry Hum Dev. 2019 Apr;50(2):209-221. doi: 10.1007/s10578-018-0833-5.

PMID:
30069665
38.

Trajectories of depressive symptoms from adolescence to emerging adulthood: The influence of parents, peers, and siblings.

Finan LJ, Ohannessian CM, Gordon MS.

Dev Psychol. 2018 Aug;54(8):1555-1567. doi: 10.1037/dev0000543.

39.

Evaluating the Feasibility and Effectiveness of an Australian Safety Planning Smartphone Application: A Pilot Study Within a Tertiary Mental Health Service.

Melvin GA, Gresham D, Beaton S, Coles J, Tonge BJ, Gordon MS, Stanley B.

Suicide Life Threat Behav. 2019 Jun;49(3):846-858. doi: 10.1111/sltb.12490. Epub 2018 Jul 12.

40.

Benchmarking of the R-7 Anisotropic Dispersion Energy Term on the S22 Dimer Test Set.

Schoeberle L, Guidez EB, Gordon MS.

J Phys Chem A. 2018 Jul 26;122(29):6100-6108. doi: 10.1021/acs.jpca.8b04451. Epub 2018 Jul 17.

PMID:
29965762
41.

Phase Ib Study of Binimetinib with Paclitaxel in Patients with Platinum-Resistant Ovarian Cancer: Final Results, Potential Biomarkers, and Extreme Responders.

Grisham RN, Moore KN, Gordon MS, Harb W, Cody G, Halpenny DF, Makker V, Aghajanian CA.

Clin Cancer Res. 2018 Nov 15;24(22):5525-5533. doi: 10.1158/1078-0432.CCR-18-0494. Epub 2018 May 29.

42.

Initiating buprenorphine treatment prior to versus after release from prison: Arrest outcomes.

Gordon MS, Blue TR, Couvillion K, Schwartz RP, O'Grady KE, Fitzgerald TT, Vocci FJ.

Drug Alcohol Depend. 2018 Jul 1;188:232-238. doi: 10.1016/j.drugalcdep.2018.04.010. Epub 2018 May 12.

43.

An investigation of the mentalization-based model of borderline pathology in adolescents.

Quek J, Bennett C, Melvin GA, Saeedi N, Gordon MS, Newman LK.

Compr Psychiatry. 2018 Jul;84:87-94. doi: 10.1016/j.comppsych.2018.04.005. Epub 2018 Apr 14.

PMID:
29727808
44.

Benchmarking the Effective Fragment Potential Dispersion Correction on the S22 Test Set.

Kim S, Kaliszewski CM, Guidez EB, Gordon MS.

J Phys Chem A. 2018 Apr 26;122(16):4076-4084. doi: 10.1021/acs.jpca.7b11628. Epub 2018 Apr 13.

PMID:
29601202
45.

Quasi-Atomic Bonding Analysis of Xe-Containing Compounds.

Duchimaza Heredia JJ, Ruedenberg K, Gordon MS.

J Phys Chem A. 2018 Apr 5;122(13):3442-3454. doi: 10.1021/acs.jpca.8b00115. Epub 2018 Mar 26.

PMID:
29533624
46.

Efficacy and safety results of depatuxizumab mafodotin (ABT-414) in patients with advanced solid tumors likely to overexpress epidermal growth factor receptor.

Goss GD, Vokes EE, Gordon MS, Gandhi L, Papadopoulos KP, Rasco DW, Fischer JS, Chu KL, Ames WW, Mittapalli RK, Lee HJ, Zeng J, Roberts-Rapp LA, Loberg LI, Ansell PJ, Reilly EB, Ocampo CJ, Holen KD, Tolcher AW.

Cancer. 2018 May 15;124(10):2174-2183. doi: 10.1002/cncr.31304. Epub 2018 Mar 13.

47.

Preliminary results for avelumab plus axitinib as first-line therapy in patients with advanced clear-cell renal-cell carcinoma (JAVELIN Renal 100): an open-label, dose-finding and dose-expansion, phase 1b trial.

Choueiri TK, Larkin J, Oya M, Thistlethwaite F, Martignoni M, Nathan P, Powles T, McDermott D, Robbins PB, Chism DD, Cho D, Atkins MB, Gordon MS, Gupta S, Uemura H, Tomita Y, Compagnoni A, Fowst C, di Pietro A, Rini BI.

Lancet Oncol. 2018 Apr;19(4):451-460. doi: 10.1016/S1470-2045(18)30107-4. Epub 2018 Mar 9.

PMID:
29530667
48.

Mentalization in Adolescents With Borderline Personality Disorder: A Comparison With Healthy Controls.

Quek J, Melvin GA, Bennett C, Gordon MS, Saeedi N, Newman LK.

J Pers Disord. 2019 Apr;33(2):145-163. doi: 10.1521/pedi_2018_32_336. Epub 2018 Feb 22.

PMID:
29469664
49.

Personal Control Over Decisions to Participate in Research by Persons With Histories of Both Substance Use Disorders and Criminal Justice Supervision.

Chen DT, Ko TM, Allen AA, Bonnie RJ, Suratt CE, Appelbaum PS, Nunes EV, Friedmann PD, Lee JD, Gordon MS, McDonald R, Wilson D, Boney TY, Murphy SM, O'Brien CP.

J Empir Res Hum Res Ethics. 2018 Apr;13(2):160-172. doi: 10.1177/1556264618755243. Epub 2018 Feb 20.

50.

Combined BRAF, EGFR, and MEK Inhibition in Patients with BRAFV600E-Mutant Colorectal Cancer.

Corcoran RB, André T, Atreya CE, Schellens JHM, Yoshino T, Bendell JC, Hollebecque A, McRee AJ, Siena S, Middleton G, Muro K, Gordon MS, Tabernero J, Yaeger R, O'Dwyer PJ, Humblet Y, De Vos F, Jung AS, Brase JC, Jaeger S, Bettinger S, Mookerjee B, Rangwala F, Van Cutsem E.

Cancer Discov. 2018 Apr;8(4):428-443. doi: 10.1158/2159-8290.CD-17-1226. Epub 2018 Feb 5.

Supplemental Content

Loading ...
Support Center